Recall Z-0366-2016— Merz North America, Inc.

Class II · Terminated

Class II FDA medical device recall by Merz North America, Inc., initiated 2015-10-26, terminated 2017-05-08. Product: Radiesse (+) Lidocaine Injectable Implant 1.5cc, P/N: 8063M0K1. Indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds.. Reason: The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect..

Recalling firm
Merz North America, Inc.
Classification
Class II
Status
Terminated
Initiated
2015-10-26
Terminated
2017-05-08
Firm location
Raleigh, NC, United States

Product description

Radiesse (+) Lidocaine Injectable Implant 1.5cc, P/N: 8063M0K1. Indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds.

Reason for recall

The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

Data sourced from openFDA. This site is unofficial and independent of the FDA.